CRT 2025
Coronary
Cardiogenic Shock
Mitchell Krucoff, MD, FACC, FAHA, FSCAI
Professor Medicine/Cardiology
Duke University Medical Center/Duke Clinical Research Institute
Durham, North Carolina, United States
Disclosure(s): Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consultant (Ongoing); Cook medical: Consultant (Ongoing); Getinge: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); InfraRedx: Consultant (Ongoing); Johnson & Johnson: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); OrbusNeich Medical Inc.: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Mohit Pahuja, MD
Assistant Professor of Medicine, Division of Interventional and advanced heart failure cardiology
University of Oklahoma Medical Center
Nichols Hills, Oklahoma, United States
Disclosure(s): No financial relationships to disclose